Target intelligence / Profile preview

RAS p21 protein activator 4C, pseudogene (RASA4CP)

Target: RASA4CP
Molecular classification: Pseudogene

Overview

RAS p21 protein activator 4C, pseudogene (RASA4CP) is classified as a pseudogene on chromosome 7 in humans. Unlike its protein-coding paralog RASA4, which is involved in regulation of the Ras signaling pathway, RASA4CP does not produce a functional protein and has no documented biological activity, disease association, or therapeutic relevance[2][5][7]. Its existence is primarily a genomic annotation, and it is not known to play any role in signaling, drug response, or pathology.

Other names: RASA4CP

Beyond the preview

Go deeper on RAS p21 protein activator 4C, pseudogene (RASA4CP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RAS p21 protein activator 4C, pseudogene (RASA4CP).

Explore the full profile